The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 134: Erik Gordon on SPACs, plus Covid-19 vaccines, & Biogen's case in Alzheimer's
24 minutes
Posted Oct 22, 2020 at 8:31 pm.
0:00
24:59
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Who's voice rings loudest at the FDA? Is it wise to give hedge funds a blank check? And how will the Biogen saga end?
Previous
Episode 133: A week of pauses, pharma’s statehouse spending, & how HBCUs approach Covid-19 trials
Next
Episode 135: Pfizer's Covid-19 mystery, Ashish Jha on pandemic response, & STAT turns 5
← See all 423 episodes of The Readout Loud
